scispace - formally typeset
R

Rita Mukhopadhyay

Researcher at FIU Herbert Wertheim College of Medicine

Publications -  45
Citations -  4564

Rita Mukhopadhyay is an academic researcher from FIU Herbert Wertheim College of Medicine. The author has contributed to research in topics: Arsenite & Arsenate reductase. The author has an hindex of 28, co-authored 45 publications receiving 4222 citations. Previous affiliations of Rita Mukhopadhyay include Florida International University & Wayne State University.

Papers
More filters
Journal ArticleDOI

Microbial arsenic: from geocycles to genes and enzymes.

TL;DR: The DNA sequencing and protein crystal structures have established the convergent evolution of three classes of arsenate reductases, which involve three cysteine thiols and S-As bond intermediates, so convergence evolution to similar mechanisms has taken place.
Journal ArticleDOI

Arsenite transport by mammalian aquaglyceroporins AQP7 and AQP9

TL;DR: The results suggest that AQP9 and AQP7 may be a major routes of arsenite uptake into mammalian cells, an observation potentially of large importance for understanding the action of arsenic as a human toxin and carcinogen, as well as its efficacy as a chemotherapeutic agent for acute promyelocytic leukemia.
Journal ArticleDOI

Arsenate reductases in prokaryotes and eukaryotes.

TL;DR: The yeast Acr2p has an active site motif HC(X)(5)R that is conserved in protein phosphotyrosine phosphatases and rhodanases, suggesting that these three groups of enzymes may have evolved from an ancestral oxyanion-binding protein.
Journal ArticleDOI

Drug Uptake and Modulation of Drug Resistance in Leishmania by an Aquaglyceroporin

TL;DR: This is the first report of the uptake of a metalloid drug by an aquaglyceroporin in Leishmania, suggesting a strategy to reverse resistance in the field.
Journal ArticleDOI

Trypanothione overproduction and resistance to antimonials and arsenicals in Leishmania.

TL;DR: It is demonstrated that promastigotes of arsenite-resistant Leishmania tarentolae have increased levels of intracellular thiols, and a model for drug resistance is proposed in which Sb(V)/As(V)-containing compounds are reduced intrACEllularly to Sb/As(III), conjugated to trypanothione, and extruded by the As-thiol pump.